department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Amzeeq · pharmadog

pharmadog
drugs
Amzeeq

drug

patient view →

Amzeeq

Marketedupdated 2mo ago

by $DERM Journey Medical Corp

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Amzeeq

generic

minocycline

indication

Acne Vulgaris

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 1, 2030

~4.2 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (21)

Sep 8, 2037method-of-use (U-2647)US 10398641
Sep 8, 2037method-of-use (U-2647)US 10849847
Oct 1, 2030method-of-use (U-2647)US 100860804.2y
Oct 1, 2030method-of-use (U-2647)US 101372004.2y
Oct 1, 2030formulationUS 102135124.2y
Oct 1, 2030formulationUS 102135124.2y
Oct 1, 2030formulationUS 102654044.2y
Oct 1, 2030formulationUS 102654044.2y
Oct 1, 2030method-of-use (U-1631)US 103221864.2y
Oct 1, 2030method-of-use (U-2647)US 105178824.2y
Oct 1, 2030method-of-use (U-2647)US 108211874.2y
Oct 1, 2030method-of-use (U-1631)US 109461014.2y
Oct 1, 2030method-of-use (U-1631)US 121383114.2y
Oct 1, 2030formulationUS 88651394.2y
Oct 1, 2030formulationUS 88651394.2y
Oct 1, 2030formulationUS 89455164.2y
Oct 1, 2030formulationUS 89455164.2y
Oct 1, 2030formulationUS 89928964.2y
Oct 1, 2030formulationUS 89928964.2y
Oct 1, 2030formulationUS 96757004.2y
Oct 1, 2030formulationUS 96757004.2y

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 7

tagApproval74 co-mentions · 37 sources
drugDYNACIN60 co-mentions · 37 sources
drugMINOCYCLINE HYDROCHLORIDE37 co-mentions · 37 sources
drugminocycline hydrochloride ER37 co-mentions · 37 sources
drugminocycline hydrochloride SR37 co-mentions · 37 sources
tagSmall Molecule37 co-mentions · 37 sources
drugminocycline37 co-mentions · 37 sources

Trials studying Amzeeq

phase2Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinibactive not recruitingn=305
EP1Topical Minocycline for CARPnot yet recruitingn=35
EP1Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabeticsrecruitingn=42
phase3Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Strokecompletedn=1,724
phase1A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participantscompletedn=76
phase4Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mgcompletedn=70
phase2Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosacompletedn=7
phase1Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adultscompletedn=69

more trials →